Clinical Trials Logo

Clinical Trial Summary

Fracture neck of femur is a common cause of hospital admission in the elderly and requires operative fixation.

Dexamethasone has the potential of inhibiting cortisol secretion. In addition, preoperative glucocorticoids improve analgesia and decrease opioid consumption with reduction in associated side effects in a variety of clinical settings.

The investigators hypothesis was that a single dose of preoperative dexamethasone enhance postoperative analgesia and attenuates the inflammatory response in patients undergoing operative fixation of fractured neck of femur, in a prospective, randomized, placebo controled trial.


Clinical Trial Description

Having obtained ethical approval and written informed consent from each, 40 patients scheduled to undergo operative fixation of fractured neck of femur will be randomized using sealed envelopes to two groups.

Patients in the Dexamethasone group receive a single dose of 0.1 mg/kg dexamethasone iv. preoperative, patients in the Placebo group receive the same amount of Normal Saline. The anaesthetic technique is standardized, salive samples, blood samples are taken and pain scores are measured on a visual analog scale postoperatively at several timepoints. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01550146
Study type Interventional
Source Cork University Hospital
Contact
Status Unknown status
Phase Phase 4
Start date July 2009
Completion date July 2012

See also
  Status Clinical Trial Phase
Completed NCT03493893 - 10 Year Review of the Experience of the PFNA ,TFNA the Affixus Nail
Suspended NCT02163343 - Serum Metal Ion Levels in Patients Who Underwent Cathcart/Corail Hemiarthroplasty for Fractured Neck of Femur
Completed NCT02057601 - Postoperative Analgesia for Fractured Neck of Femur With Periarticular Infiltration of Local Anaesthetic N/A
Completed NCT01527812 - Optimal Positioning of Local Anaesthetic in Femoral Nerve Block Prior to Hip Surgery N/A